Lupin has received Central Drugs Standard Control Organisation (CDSCO) approval for Acotiamide 100 mg tablets used for the treatment of indigestion. The drug Acotiamide is a first-in-class novel drug to be introduced into the Indian pharmaceutical market which could benefit patients suffering from dyspepsia or indigestion, amongst the most common stomach complaints encountered in clinical practice. The drug
Acotiamide is approved by the Pharmaceuticals and Medical Devices Agency (PMDA) Japan and is actively marketed in Japan.
Company Profile : Lupin Ltd
Leave a Reply